Atrial Natriuretic Factor
Research News and Information

Monday, November 23, 2009

New treatment with human atrial natriuretic peptide for postoperative myonephropathic metabolic syndrome.

29 Sep 2009 A 49-year-old man had sudden chest pain and paralysis of the lower right limb. An acute aortic dissection was diagnosed in a computed tomography scan and the patient underwent an emergency operation. After the operation, myonephropathic metabolic ... Read more...

Influence of continuous infusion of low-dose human atrial natriuretic peptide on renal function during cardiac surgery: a randomized controlled study.

13 Sep 2009 OBJECTIVES: The purpose of this study was to determine the effect of human atrial natriuretic peptide (hANP) in patients who underwent coronary artery bypass grafting (CABG) on renal function. BACKGROUND: Acute renal failure after cardiac surgery is ... Read more...

A human atrial natriuretic peptide gene mutation reveals a novel peptide with enhanced blood pressure-lowering, renal-enhancing, and aldosterone-suppressing actions.

6 Sep 2009 OBJECTIVES: We sought to determine the physiologic actions and potential therapeutic applications of mutant atrial natriuretic peptide (mANP). BACKGROUND: The cardiac hormone atrial natriuretic peptide (ANP) is a 28-amino acid (AA) peptide that ... Read more...

Latest indexed articles for 'Atrial Natriuretic Factor'

These are the very latest articles for this heading:

• New treatment with human atrial natriuretic peptide for postoperative myonephropathic metabolic syndrome. 29 Sep 2009
• Renal protective effects and prevention of contrast-induced nephropathy by atrial natriuretic peptide can it work? 20 Sep 2009
• Influence of continuous infusion of low-dose human atrial natriuretic peptide on renal function during cardiac surgery: a randomized controlled study. 13 Sep 2009
• Cardiac natriuretic peptides: gaining further insights into structure-function relationships. 6 Sep 2009
• A human atrial natriuretic peptide gene mutation reveals a novel peptide with enhanced blood pressure-lowering, renal-enhancing, and aldosterone-suppressing actions. 6 Sep 2009
• Brain-type natriuretic peptide at birth reflects foetal maturation and antenatal stress. 30 Aug 2009
• Baroreflex sensitivity is impaired in patients with obstructive jaundice. 30 Aug 2009
• Hypertrophic gene expression induced by chronic stretch of excised mouse heart muscle. 30 Aug 2009
• Natural antisense transcript of natriuretic peptide precursor A (NPPA): structural organization and modulation of NPPA expression. 9 Aug 2009
• Hypothermic circulatory arrest: renal protection by atrial natriuretic peptide. 30 Jul 2009
• Validity, prognostic value and optimal cutoff of respiratory muscle strength in patients with chronic heart failure changes with beta-blocker treatment. 30 Jul 2009
• Biomarkers of left atrial volume: a longitudinal study in patients with end stage renal disease. 25 Jul 2009
• Impaired recovery of blood flow after hind-limb ischemia in mice lacking guanylyl cyclase-A, a receptor for atrial and brain natriuretic peptides. 21 Jul 2009
• Impairment of diastolic function by lack of frequency-dependent myofilament desensitization rabbit right ventricular hypertrophy. 19 Jul 2009
• Effects of fixed-dose isosorbide dinitrate/hydralazine on diastolic function and exercise capacity in hypertension-induced diastolic heart failure. 18 Jul 2009
• Modulation of lung inflammation by vessel dilator in a mouse model of allergic asthma. 15 Jul 2009
• The cardioprotective effects of fish oil during pressure overload are blocked by high fat intake: role of cardiac phospholipid remodeling. 11 Jul 2009
• [Chronic obstructive pulmonary disease and heart failure] 10 Jul 2009
• Excess of glucocorticoid induces cardiac dysfunction via activating angiotensin II pathway. 29 Jun 2009
• Human plasmacytoid dendritic cells express an atrial natriuretic peptide receptor, guanylyl cyclase-A. 29 Jun 2009

See a longer list of these articles.

Technical information about 'Atrial Natriuretic Factor'

Definition: A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS.

Chemical name: Atriopeptin

Registry Number: 85637-73-6

Descriptor UI: D009320

Alternative terms: Atrial Natriuretic Factor; Auriculin; ANP; Natriuretic Peptides, Atrial; ANF; Atriopeptins; Atrial Natriuretic Peptides; Peptides, Atrial Natriuretic; beta-Atrial Natriuretic Peptide; beta Atrial Natriuretic Peptide; beta-ANP; beta ANP; alpha-ANP Dimer; alpha ANP Dimer; alpha-Atrial Natriuretic Peptide; alpha Atrial Natriuretic Peptide; ANP-(99-126); Atriopeptin (99-126); Cardionatrin I; Atrial Natriuretic Factor (99-126); ANF (1-28); Atriopeptin (1-28); Atrial Natriuretic Factor (1-28); gamma ANP (99-126); alpha ANP; Cardiodilatin (99-126); ANP Prohormone (99-126); ANF (99-126); ANP (1-28); Atrial Natriuretic Factor Precursors; Prepro-Cardiodilatin-Atrial Natriuretic Factor; Prepro Cardiodilatin Atrial Natriuretic Factor; Prepro-ANP; Prepro ANP; ANF Precursors; Cardiodilatin Precursor; Prepro-CDD-ANF; Prepro CDD ANF; gamma-Atrial Natriuretic Peptide; gamma Atrial Natriuretic Peptide; Atriopeptin Prohormone (1-126); Proatrial Natriuretic Factor; Pronatriodilatin; Atriopeptin 126; Cardionatrin IV; Atrial Natriuretic Factor Prohormone; Atrial Natriuretic Factor (1-126); Atrial Natriuretic Peptide (1-126); Atriopeptigen; ANF (1-126); ANP (1-126); Atrial Pronatriodilatin; Pro-ANF; Pro ANF; ProANF;

Related Mesh Headings: Receptors, Atrial Natriuretic Factor;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications; agonists;

Tree Number: D06.472.699.584.500; D12.644.548.585.500;

History Note: 1992, use NATRIURETIC PEPTIDES, ATRIAL 1986-1991; use ATRIAL NATRIURETIC FACTOR (NM) for ATRIAL NATRIURETIC FACTOR (99-126) 1987-2003; use ATRIAL NATRIURETIC FACTOR (NM) for ATRIAL NATRIURETIC FACTOR (1-28) 1992-2003; use ATRIAL NATRIURETIC FACTOR (NM) for CARDIONATRIN IV 1986-2003; use ATRIAL NATRIURETIC FACTOR (NM) for ATRIOPEPTIGEN 1985-2003; use ATRIAL NATRIURETIC FACTOR (NM) for ATRIAL NATRIURETIC FACTOR PRECURSORS 1985-2003